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Abstract
Background. Infarct size is correlated with duration of coronary artery occlusion. Evidence
suggests that transport for primary angioplasty improves outcomes, but there is no agreement
regarding differences in prognosis between men and women. We compared outcomes in men and
women with ST-segment elevation myocardial infarction (STEMI) transferred from another
hospital against those who had been transported directly to an invasive treatment center.
Methods. Data was collected between June 2005 and May 2006 from a registry of 26,035 patients
with STEMI and in whom primary angioplasty had been performed.
Results. A total of 10,708 patients underwent primary angioplasty. Of these, 3,359 men and
1,469 women were transported directly, while 4,135 men and 1,745 women were transferred
from another site. In-hospital mortality and at one month, six months and 12 months after
hospital discharge was significantly higher in women than in men. The prognosis of women
transported directly was similar to that of women transferred from another site. However, there
was a tendency, albeit insignificant, towards higher mortality at six and 12 months in women
transported from another hospital.
Conclusions. To reduce mortality in STEMI, an immediate reperfusion must not be delayed.
This conclusion is valid particularly for women who are at greater risk of death. (Cardiol J
2011; 18, 3: 254–260)
Key words: ST-segment elevation myocardial infarction, time to reperfusion,
transfer, gender
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Introduction
In ST-segment elevation myocardial infarction
(STEMI), infarct size is correlated with duration of
coronary artery occlusion. De Luca et al. [1] dem-
onstrated that every 30 min delay to revasculariza-
tion will increase annual mortality by 7.5%. None-
theless, the available evidence suggests that trans-
port for primary angioplasty improves short- and
long-term outcomes better than immediate throm-
bolysis [2, 3]. However, the DANAMI-2 [4] study
demonstrated no such benefit in diabetic patients.
The same may apply to other patients with STEMI.
There is controversy regarding differences in the
clinical course of myocardial infarction (MI) and
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prognosis between men and women. Some investi-
gators ascribe higher mortality among women to
a worse risk profile and less aggressive treatment
strategy [5–7]. Others believe that female gender
is an independent predictor of adverse outcome [8, 9].
It is well-known that women are more prone to
complications related to invasive procedures [10].
The purpose of the present study was to compare
outcomes in men and women with STEMI trans-
ferred to a cath lab from another hospital against
outcomes in those transported directly to an inva-
sive treatment center.
Methods
The data is based on the Polish Registry of
Acute Coronary Syndromes (PL-ACS) [11]. The
present data was collected between June 2005 and
May 2006. The Registry includes data on patients
from 456 sites across Poland. Mortality data after
hospital discharge was obtained from the National
Health Fund database for all included subjects. All
consecutive patients presenting with STEMI diag-
nosed according to the available guidelines were
enrolled in the Registry. Of these, patients who
underwent primary angioplasty within 12 hours from
symptom onset were analyzed in our study. Demo-
graphic features such as age and gender, concomi-
tant diseases, coronary risk factors, previous MI and
revascularization, were analyzed. The time from
symptom onset to percutaneous coronary interven-
tion (PCI), time from admission to PCI, TIMI flow
before and after revascularization, left ventricular
ejection fraction (LVEF), cardiovascular, neurologi-
cal and hemorrhagic complications were recorded.
The primary end point was death during hospitaliza-
tion, at one month, six months and 12 months after
hospital discharge.
Statistical analysis
Continuous variables, depending on the data
distribution, are expressed as mean ± SD or medi-
an and interquartile range. The significance of dif-
ferences between groups was determined by use
of Student’s t-test or the Mann-Whitney U test for
those variables which did not conform to a normal
distribution. The type of parametric test depended
on the homogeneity of variances which was tested
using the F-test. Qualitative variables were tested
using the c2 test. Mortality at 12 months was ana-
lyzed using Kaplan-Meier survival curves with log
rank test. A multivariate Cox proportional hazard
model regression was performed to adjust the influ-
ence of the transfer of patients on 12-month mortality
as well as to identify predictors of 12-month mortality
in women and men. Hazard ratios (HRs) and 95%
confidence intervals (CIs) were calculated. A p value
£ 0.05 (two-tailed) was considered significant.
Results
Basic characteristics
Within the study period, the PL-ACS Registry
included data on 26,035 patients with STEMI. Of
these, 10,708 (41.1%) patients i.e. 7,494 men and
3,214 women (70% vs 30%; p < 0.0001) underwent
primary angioplasty. In this population, 4,827 (45%)
patients (3,358 [69.6%] men and 1,469 [30.4%]
women) were transported directly to a hemodynam-
ic laboratory, while 5,880 (55%) patients i.e. 4,135
(70.3%) men and 1,745 (29.7%) women were trans-
ferred from another site. As compared to those ta-
ken from home, both men and women who were
transferred from another site were slightly young-
er, but women more often had diabetes mellitus,
hypercholesterolemia and obesity, while men had
previous MI. In both groups, women were older
than men, more frequently had arterial hyperten-
sion, diabetes mellitus and obesity, but less often
smoked and less frequently had previous MI and
coronary artery bypass grafting (CABG) (Table 1).
Time to PCI
In both groups, PCI within three hours of symp-
tom onset was performed more frequently in men
than in women (55% vs 51.5%, p = 0.033; 39.9% vs
35.3%, p = 0.001, respectively). The mean time
from symptom onset to PCI was significantly long-
er both for female and male patients transferred
from another site, and additionally longer for wo-
men in both groups. By contrast, time from admis-
sion to PCI was shorter for patients transferred
from another site and comparable in men and wo-
men (Table 2).
PCI success
In both groups and both genders, the percent-
age of infarct-related artery stenting was similar and
exceeded 90%. GP IIb/IIIa receptor antagonists were
administered in roughly one third of all patients; sig-
nificantly more frequently in patients transported
directly from home, and significantly less often in
women. The rate of TIMI 0 flow prior to treatment
was similar in men and women in both groups. TIMI
3 flow after PCI was achieved significantly less fre-
quently in women than in men (Table 2).
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Table 2. Time to reperfusion, adjunctive treatment and angiographic outcome of primary percutaneous
coronary intervention (PCI).
Direct Transferred from Significance
transport another hospital between groups (p)
Females Males P Females Males P Females Males
Onset-to-balloon: 0–3 h 699 1724 0.033 582 1571 0.0010 < 0.0001 < 0.0001
(51.5%) (55%) (35.3%)  (39.9%)
Onset-to-balloon: 3–12 h 658 1413 0.033 1069 2362 0.0010 < 0.0001 < 0.0001
(48.5%) (45%) (64.7%) (60.1%)
Onset-to-balloon [min] 231 220 0.0081 272 260 0.0009 < 0.0001 < 0.0001
(160–350) (150–330) (195–395) (180–380)
Door-to-balloon [min] 50 49 0.078 40 40 0.21 < 0.0001 < 0.0001
(33–80)  (30–75) (28–60) (26–60)
GP IIb/IIIa infusion 406 1032 0.031 411 1126 0.0034 0.0081 0.0009
(27.6%) (30.7%) (23.6%) (27.2%)
Culprit lesion stenting 1345 3118 0.12 1609 3871 0.050 0.50 0.19
(91.6%) (92.9%) (92.2%) (93.6%)
Pre-procedural TIMI flow:
0 989 2313 0.29 1133 2615 0.16 0.18 < 0.0001
(67.5%) (69%) (65.2%) (63.3%)
1 208 421 0.12 185 488 0.20 0.0023 0.32
(14.2%) (12.6%) (10.6%) (11.8%)
2 159 355 0.79 233 568 0.73 0.028 < 0.0001
(10.8%) (10.6%) (13.4%) (13.7%)
3 110 264 0.66 187 463 0.62 0.0016 < 0.0001
(7.5%) (7.9%) (10.8%) (11.2%)
TIMI flow following PCI:
0 40 64 0.072 50 70 0.0037 0.81 0.49
(2.7%) (1.9%) (2.9%) (1.7%)
1 37 46 0.0047 36 44 0.0025 0.39 0.23
(2.5%) (1.4%) (2.1%) (1.1%)
2 72 166 0.95 103 215 0.28 0.21 0.62
(4.9%) (4.9%) (5.9%) (5.2%)
3 1320 3082 0.030 1556 3806 0.0004 0.53 0.68
(89.9%) (91.8%) (89.2%) (92%)
Table 1. Basic clinical characteristics.
Direct transport Transferred from another Significance
(n = 4,827) hospital (n = 5,880) between groups (p)
Females Males P Females Males P Females Males
(n = 1,469, (n = 3,358, (n = 1,745, (n = 4,135,
30.4%)   69.6%)   29.7%) 70.3%)
Age (mean ±SD) 71.0 ± 11.8 62.9 ± 12.3 < 0.0001 66.8 ± 11.4 60.4 ± 11.4 < 0.0001 < 0.0001 < 0.0001
Age ≥ 65 873 1199 < 0.0001 1018 1486 < 0.0001 0.53 0.84
(59.4%) (35.7%) (58.3%) (35.9%)
Age < 65 596 2159 < 0.0001 727 2649 < 0.0001 0.53 0.84
(40.6%) (64.3%) (41.7%) (64.1%)
Hypertension 973 1850 < 0.0001 1152 2352 < 0.0001 0.90 0.12
(66.2%) (55.1%) (66%) (56.9%)
Diabetes 342 458 < 0.0001 459 613 < 0.0001 0.048 0.14
(23.3%) (13.6%) (26.3%) (14.8%)
≠Cholesterol 594 1454 0.064 802 1830 0.23 0.0017 0.41
(40.4%) (43.3%) (46%) (44.3%)
Smoking 445 1712 < 0.0001 526 2185 < 0.0001 0.93 0.11
(30.3%)  (51%) (30.1%) (52.8%)
BMI > 30 kg/m2 300 418 < 0.0001 447 501 < 0.0001 0.0005 0.66
(20.4%) (12.4%) (25.6%) (12.1%)
Previous MI 140 376 0.085 164 528 0.0003 0.90 0.038
(9.5%) (11.2%) (9.4%)  (12.8%)
Previous PCI 11 44 0.091 14 49 0.19 0.86 0.63
(0.7%) (1.3%) (0.8%) (1.2%)
Previous CABG 39 158 0.0009 45 187 0.0005 0.89 0.71
(2.7%) (4.7%) (2.6%) (4.5%)
BMI — body mass index; MI — myocardial infarction; PCI — percutaneous coronary intervention; CABG — coronary artery by-pass grafting
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In-hospital course
The rate of in-hospital complications in patients
with STEMI undergoing primary angioplasty was
low. Reinfarction (STEMI or NSTEMI), stroke and
non-coronary death were equally frequent in all study
groups. Bleeding complications were most frequent
among women transferred from another site. LVEF
prior to discharge was comparable in men and wo-
men. Among patients transported directly from
home, LVEF more frequently exceeded 50%, while
among those transferred from another site, LVEF
tended to range from 30 to 50% (Table 3).
Prognosis
Mortality at all time points was significantly high-
er in women than in men. The prognosis of women
transported directly from home was similar to that of
women transferred from another site. However, there
was a tendency, albeit insignificant, toward higher
mortality at six and 12 months in women transported
from another hospital (Table 4). Figure 1 depicts Ka-
plan-Meier mortality curves in all study groups.
When analyzing mortality depending on total
ischemic time measured by onset-to-balloon time
(regardless of whether a patient was transported di-
rectly or not) there is a clear significant tendency
that the longer the time to recanalization of the in-
farct-related artery, the higher the mortality. More-
over, mortality in women is higher at all time de-
lays (Table 5).
Table 3. Left ventricular ejection fraction and in-hospital complications.
Direct Transferred from Significance between
transport  another hospital  groups (p)
Females Males P Females Males P Females Males
LVEF:
> 50% 582 (54.6%) 1353 (52.2%) 0.17 573 (46.6%) 1326 (45.6%) 0.53 0.0001 < 0.0001
30–50% 447 (42%) 1135 (43.8%) 0.32 597 (48.6%) 1451 (49.8%) 0.46 0.0015 < 0.0001
< 30% 36 (3.4%) 105 (4%) 0.34 59 (4.8%) 134 (4.6%) 0.78 0.087 0.31
Complications:
STEMI 35 (2.4%) 66 (2%) 0.35 34 (1.9%) 60 (1.5%) 0.16 0.40 0.085
NSTEMI/UA 10 (0.7%) 21 (0.6%) 0.82 12 (0.7%) 23 (0.6%) 0.55 0.98 0.70
Stroke 7 (0.5%) 9 (0.3%) 0.37 15 (0.9%) 6 (0.1%) < 0.0001 0.19 0.24
Bleeding 17 (1.2%) 21 (0.6%) 0.054 27 (1.5%) 17 (0.4%) < 0.0001 0.34 0.19
re-PCI (TLR) 11 (0.7%) 39 (1.2%) 0.19 19 (1.1%) 44 (1.1%) 0.93 0.32 0.69
LVEF — left ventricular ejection fraction; STEMI — ST-segment elevation myocardial infarction; NSTEMI — non-ST-segment elevation myocardial
infarction; UA — unstable angina; PCI — percutaneous coronary intervention; TLR — target lesion revascularization
Table 4. In-hospital, 30-day, six-month and one year mortality.
Direct Transferred from Significance
transport another hospital between groups (p)
Females Males P Females Males P Females Males
In-hospital 88 (6%) 137 (4.1%) 0.0038 111 (6.4%) 139 (3.4%) < 0.0001 0.66 0.10
30-day 102 (6.9%) 156 (4.6%) 0.0011 129 (7.4%) 196 (4.7%) < 0.0001 0.62 0.85
12-month 152 (10.3%) 278 (8.3%) 0.020 215 (12.3%) 336 (8.1%) < 0.0001 0.080 0.81
Figure 1. Kaplan-Meier curves for one year mortality in
all study groups.
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Multivariate analysis
In multivariate analysis for all patients, age,
cardiac arrest, anterior MI and Killip class 3 or 4
significantly influenced 12-month mortality. No sig-
nificant impact of transfer from another hospital was
observed. In women, the most important factors
increasing mortality were Killip class 3 or 4 (HR
4.21, 95% CI 3.27–5.43, p < 0.0001) and less than
TIMI 3 grade flow following primary PCI (HR 3.25,
95% CI 2.58–4.08, p < 0.0001). Similar findings
were obtained in men (Tables 6, 7).
Discussion
‘Time is muscle’ is a well-known concept re-
garding patients with STEMI [1]. In an effort to re-
duce delay from pain onset to recanalization of the
infarct-related artery, physicians in hospitals with-
out invasive cardiac facilities frequently face a di-
lemma as to whether to transfer a patient to a cath
lab or to provide treatment on site.
The DANAMI-2 [12] and PRAGUE-2 [13]
trials demonstrated a positive effect of transport to
primary angioplasty as compared to fibrinolysis on
site regarding 30-day survival in women. The avail-
able literature includes no comparison that takes
into account sex differences in patients with STEMI
without transport and who are transferred to anoth-
er site to undergo primary PCI. In our study, 30-
-day mortality did not differ between women trans-
ferred to primary angioplasty and those admitted
directly to a cath lab. Unlike men, there is a ten-
dency toward higher mortality at one year among
transported women, while the 12-month prognosis
of men is similar in both groups (Kaplan-Meier sur-
vival curves are superimposed) despite the signifi-
cant prolongation of onset-to-balloon time in the
transported group. The delay related to transfer
from another site was about 40 min in patients of
both genders. Thus we presume that worse long-
-term prognosis in transferred women is related not
only to delayed reperfusion, but also to worse base-
line characteristics including more frequent diabe-
tes that has been reported to diminish long-term
benefits from transport to primary PCI [4].
An incomplete reading of the present study
might lead to the false conclusion that time to re-
vascularization is not associated with mortality,
something which obviously conflicts with previous
reports and guidelines. In our study, transfer from
another hospital has no significant influence on
mortality in multivariate analysis.
To clarify this, we performed an additional ana-
lysis of mortality depending on onset-to-balloon
time. It can clearly be seen that mortality, both in-
hospital and long-term, depends on total ischemic
time regardless of mode of transport, as the two
stage transport does not have to be a priori too long.
The second important finding is that women have
Table 5. In-hospital and 12-month mortality depending on onset-to-balloon time in patients transported
directly and transferred from another hospital.
Time delay Direct transport Transferred
Females Males P Females Males P
In hospital: 0–3 h 5.6% 4.8% 0.53 6.5% 2.9% 0.0018
3–12 h 6.3% 3.4% 0.0004 6.3% 3.4% < 0.0001
12-month: 0–3 h 9.0% 8.1% 0.58 11.7% 7.1% 0.007
3–12 h 11.2% 8.0% 0.0056 12.3% 8.3% < 0.0001
Table 6. Multivariate analysis of 12-month
mortality, all patients.
HR (95% CI) P
Age (for each 1.68 (1.58–1.79) < 0.0001
10 years more)
Female sex 1.00 (0.87–1.14) 0.95
Hypertension 0.95 (0.83–1.09) 0.45
Diabetes 1.48 (1.28–1.71) < 0.0001
Hypercholesterolemia 0.81 (0.71–0.92) 0.0018
Smoking 1.01 (0.88–1.18) 0.85
Obesity 1.04 (0.88–1.24) 0.64
Prior MI 1.33 (1.11–1.60) 0.0024
Prior PCI or CABG 1.21 (0.90–1.62) 0.20
CA before admission 1.74 (1.39–2.17) < 0.0001
Anterior MI 1.55 (1.37–1.76) < 0.0001
Killip class 3 or 4 6.67 (5.77–7.71) < 0.0001
Transfer from 1.01 (0.89–1.15) 0.88
another hospital
HR — hazard ratio; MI — myocardial infarction; PCI — percutaneous
coronary intervention; CABG — coronary artery bypass grafting;
CA — cardiac arrest
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higher mortality than their male counterparts, es-
pecially when primary PCI is performed more than
three hours after symptom onset.
At first, it was believed that door-to-balloon time
was the most important factor related to prognosis
[14]. Later, Antoniucci et al. [15] and De Luca et al.
[1] demonstrated that onset-to-balloon time (i.e. to-
tal ischemic time) is equally significant. In the present
study it is shorter (220 min in men and 231 min in
women) than in the PRAGUE-2 study [2] (about
277 min for transferred patients), but longer than in
the DANAMI-2 trial [12] (188 min for on-site treat-
ment patients and 224 min for those transferred from
another site) and in the study by Le May et al. [16]
(158 min and 230 min, respectively). The shorter de-
lay recorded in those studies was probably due to the
fact that they were randomized controlled studies in-
corporating many fewer patients and in a smaller area.
Also,  awareness of participating in a study could have
exerted a positive influence on transport organization,
thus shortening the delay. The US National Registry
of Myocardial Infarction (NRMI) includes data on time
from first medical contact to reperfusion [17]. In 1999–
–2002, it was 180 min on average (including transport
to PCI 120 min on average). According to the National
Cardiovascular Data Registry [15], it improved to
153 min (including transport to PCI 109 min) in
2005–2006. Moreover, a standardized protocol and
integrated regional system of transfer for STEMI
patients allow further time savings [18].
In contrast to the US data [17], the patients in
the present study who were transferred from an-
other site had shorter PCI hospital door-to-balloon
time than those who were transported directly from
home. This difference was probably related to ear-
lier notification of the hemodynamic team and di-
rect patient transport to the cath lab. It is impor-
tant to note that although time from symptom on-
set to PCI was on average 11–12 min longer in
women, time from hospital admission to PCI was
comparable in patients of both genders.
Recently, gender differences in the course and
prognosis of STEMI have been studied extensive-
ly [5–9]. Similarly to the present study, women with
STEMI have been found to be older and to have
more concomitant diseases than men. This un-
doubtedly increases mortality rates in women with
STEMI, and, according to some investigators, if we
adjust for these factors, the risk will equalize for
men and women [5–7].
Other factors like younger age, pretreatment
with aspirin, clopidogrel and heparin, and more fre-
quent pre-procedural TIMI grade 2 and 3 flow in the
transferred group may affect both short- and long-
-term prognosis.
Another reason for worse prognosis in women
may be the less frequent use of an invasive approach
[5–7]. In our study, all women underwent primary
angioplasty, but nevertheless their mortality rates
were higher than in men. This could be a result of
Table 7. Multivariate analysis of 12-month mortality for both genders.
Females Males
HR (95% CI) P HR (95% CI) P
Age (for each 10 years more) 1.48 (1.32–1.66) < 0.0001 1.56 (1.45–1.68) < 0.0001
Hypertension 1.04 (0.83–1.31) 0.72 0.96 (0.81–1.13) 0.62
Diabetes 1.17 (0.93–1.47) 0.19 1.45 (1.2–1.76) 0.0001
Hypercholesterolemia 0.79 (0.64–0.99) 0.042 0.81 (0.68–0.97) 0.018
Smoking 0.86 (0.63–1.18) 0.36 1.04 (0.88–1.23) 0.61
Obesity 1.11 (0.87–1.42) 0.42 0.92 (0.72–1.18) 0.52
Prior MI 1.52 (1.13–2.04) 0.0051 0.94 (0.74–1.2) 0.63
Prior PCI or CABG 1.05 (0.60–1.84) 0.85 1.32 (0.93–1.86) 0.12
CA before admission 2.07 (1.36–3.14) 0.0006 1.71 (1.31–2.24) 0.0001
Anterior MI 1.36 (1.10–1.69) 0.0052 1.29 (1.09–1.52) 0.0025
Killip class 3 or 4 4.21 (3.27–5.43) < 0.0001 5.03 (4.14–6.1) < 0.0001
Onset-to-balloon 0–3 h 1.02 (0.80–1.32) 0.85 1.01 (0.84–1.22) 0.89
TIMI < 3 after PCI 3.25 (2.58–4.08) < 0.0001 2.73 (2.26–3.3) < 0.0001
Multivessel disease 1.77 (1.40–2.23) < 0.0001 1.43 (1.2–1.7) < 0.0001
LVEF (per 5% less) 1.18 (1.11–1.24) < 0.0001 1.19 (1.14–1.24) < 0.0001
HR — hazard ratio; CI — confidence interval; MI — myocardial infarction; PCI — percutaneous coronary intervention; CABG — coronary artery
bypass grafting; CA — cardiac arrest; LVEF — left ventricular ejection fraction
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the worse baseline clinical profile, longer delay from
symptom onset to PCI, suboptimal revasculariza-
tion and more frequent bleeding complications.
Limitations of the study
This is a large multicenter registry with all the
limitations of such a study, but it has the advantage
of consisting of a ‘real life’ population. However,
a major limitation is the fact that gender is not the
only difference between the two groups, and differ-
ences in baseline characteristics all indicate a worse
risk profile in women. Finally, a history of coronary
events was significantly more frequent in men, and
it is conceivable that patients with past MI or re-
vascularization were already taking drugs that could
beneficially impact on the acute event. Another
important issue is that the slightly higher mortali-
ty in women dispatched to interventional facility
may reflect a bias related to the initial decision
made.
Conclusions
To reduce mortality in STEMI, a decision as
to immediate reperfusion must not be delayed and
all patients without contraindications to PCI should
be referred for invasive treatment. Our main con-
clusion is that after the initial diagnosis of STEMI,
all activities of medical staff should be guided by the
concept that ‘time is muscle’ and no further delay
in reperfusion should be allowed, even if transport
to another facility is required. This conclusion is
valid particularly for women who are at greater risk
of death.
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